Amundi Asset Management US’s Idexx Laboratories IDXX Stock Holding History

Amundi Asset Management US’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$167M	Buy	341,404 +19,419	+6%	+$9.73M	0.13%	182
2020 Q4	$161M	Buy	321,985 +42,630	+15%	+$19.1M	0.14%	166
2020 Q3	$110M	Buy	279,355 +35,025	+14%	+$12.9M	0.12%	183
2020 Q2	$80.7M	Buy	244,330 +89,672	+58%	+$26M	0.1%	223
2020 Q1	$37.5M	Sell	154,658 -8,272	-5%	-$2.16M	0.07%	270
2019 Q4	$42.5M	Buy	162,930 +42,367	+35%	+$11.2M	0.05%	355
2019 Q3	$32.8M	Sell	120,563 -23,811	-16%	-$6.63M	0.05%	378
2019 Q2	$39.8M	Sell	144,374 -17,691	-11%	-$4.36M	0.03%	381
2019 Q1	$36.2M	Buy	162,065 +85,680	+112%	+$17.7M	0.05%	354
2018 Q4	$14.2K	Buy	76,385 +20,724	+37%	+$4.25M	0.01%	559
2018 Q3	$13.9M	Buy	55,661 +19,475	+54%	+$4.73M	0.02%	655
2018 Q2	$7.89M	Buy	36,186 +10,747	+42%	+$2.21M	0.01%	800
2018 Q1	$4.87M	Buy	25,439 +1,467	+6%	+$271K	0.01%	866
2017 Q4	$3.75M	Buy	+23,972	New	+$3.77M	0.01%	919

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Amundi Asset Management US's IDXX Position: Q1 2021 in Review

Amundi Asset Management US increased its Idexx Laboratories (IDXX) stake by 6% in Q1 2021, buying an estimated $9.73M and bringing the position to 341,404 shares worth $167M. The position accounts for 0.13% of the portfolio, ranked #182.

Amundi Asset Management US first reported a position in IDXX in Q4 2017 and has held it in 14 quarters since. 1,012 funds tracked by Wall St. Rank hold IDXX as of Q1 2021.

Amundi Asset Management US held 341,404 shares of Idexx Laboratories worth $167M as of Q1 2021.
Amundi Asset Management US bought 19,419 Idexx Laboratories shares in Q1 2021, an estimated $9.73M.
Idexx Laboratories made up 0.13% of Amundi Asset Management US's portfolio in Q1 2021, its #182 holding.
Amundi Asset Management US first reported a position in Idexx Laboratories in Q4 2017 and has held it in 14 quarters since.
1,012 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.